Both TD-NEPC and DU145, which express high levels of CDC7, were more sensitive to TAK-931 treatment compared to the adenocarcinoma cell lines including PC3, LNCaP-RFP, and RPWE-1, which express lower CDC7 levels (Fig. 4A). Here, CDC7 is linked to adenocarcinoma.